NCT00494949 - Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

August 31, 2006

Conditions

HypotensionHypoxia

Interventions

DRUG

Hemospan (MP4OX)

200, 400, 600, 750, or 1000 mL of Hemospan (MP4OX)

DRUG

Ringer's lactate

200, 400, 600, 750, or 1000 mL of Ringer's lactate solution

Trial Locations (2)

Department of Orthopedics, Karolinska Hospital, Stockholm

Department of Orthopedics, Stockholm Söder Hospital, Stockholm